Detalhe da pesquisa
1.
A novel modality of BAFF-specific inhibitor AMG623 peptibody reduces B-cell number and improves outcomes in murine models of autoimmune disease.
Clin Exp Rheumatol
; 30(2): 197-201, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22325420